Results 171 to 180 of about 2,668,255 (357)

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells [PDF]

, 1990
Tucker W. LeBien, RL Elstrom, Melinda L. Moseley, JH Kersey, Frank Griesinger   +4 more
openalex   +1 more source

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia [PDF]

, 2023
Ibrahim Aldoss, Samer K. Khaled, Yan Wang, Xiuli Wang, Joycelynne Palmer, Mary C. Clark, Jamie R. Wagner, Jinny Paul, Vibhuti Vyas, Christine E. Brown, Stephen J. Forman   +10 more
openalex   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

The T-cell receptor repertoire of wild mice. [PDF]

Discov Immunol
Cohen JA, Hunter-Barnett S, Nageswaran G, Byrne S, Freeman G, Cowley MV, Chain B, Viney M.   +7 more
europepmc   +1 more source

Assessing T Cell Receptor Affinity and Avidity Against Tumor Antigens

, 2017
Mathilde Allard, Michaël Hebeisen, Nathalie Rufer   +2 more
openalex   +1 more source

T-cell Receptor-engineered T-cells [PDF]

, 2020
openaire   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

The TCXpress lane to T-cell receptor-engineered T cells. [PDF]

Blood Adv
Biernacki MA.
europepmc   +1 more source

A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line. [PDF]

, 1986
Bernhard Manger, Amy R. Weiss, K J Hardy, John D. Stobo   +3 more
openalex   +1 more source